Skip to main content

XBiotech Inc.

XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626878

No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding XBiotech Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of XBIT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6556−9
Shares4.33M4.11M−215.6K (−5.0%)
Value$74.1M$66.8M−$7.39M (−10.0%)

New holders (2)

Institutions that held XBiotech Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to XBIT in Q2 2021
InstitutionSharesValue% of portfolio
Thomasville National Bank13,350$221.0K0.02%
Advisory Services Network, LLC200$3.00K0.00%

Sold out (11)

Institutions that held XBiotech Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of XBIT in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Caas Capital Management LP58,047$997.0K
California Public Employees Retirement System29,600$508.0K
Susquehanna International Group, LLP21,664$372.0K
Group One Trading, L.P.12,999$223.0K
ExodusPoint Capital Management, LP12,811$220.0K
Millennium Management LLC10,056$173.0K
Bank of Montreal439$8.00K
Quantbot Technologies LP300$5.00K
NEXT Financial Group, Inc300$5.00K
Manchester Financial Inc259$4.00K
FMR LLC125$2.00K